Literature DB >> 29211346

Chemogenomic Active Learning's Domain of Applicability on Small, Sparse qHTS Matrices: A Study Using Cytochrome P450 and Nuclear Hormone Receptor Families.

Christin Rakers1, Rifat Ara Najnin2, Ahsan Habib Polash2, Shunichi Takeda2, J B Brown3.   

Abstract

Computational models for predicting the activity of small molecules against targets are now routinely developed and used in academia and industry, partially due to public bioactivity databases. While models based on bigger datasets are the trend, recent studies such as chemogenomic active learning have shown that only a fraction of data is needed for effective models in many cases. In this article, the chemogenomic active learning method is discussed and used to newly analyze public databases containing nuclear hormone receptor and cytochrome P450 enzyme family bioactivity. In addition to existing results on kinases and G-protein coupled receptors, results here demonstrate the active learning methodology's effectiveness on extracting informative ligand-target pairs in sparse data scenarios. Experiments to assess the domain of the applicability demonstrate the influence of ligand profiles of similar targets within the family.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  active learning; chemogenomics; chemoinformatics; cytochromes; hormone receptors

Mesh:

Substances:

Year:  2018        PMID: 29211346     DOI: 10.1002/cmdc.201700677

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Active learning effectively identifies a minimal set of maximally informative and asymptotically performant cytotoxic structure-activity patterns in NCI-60 cell lines.

Authors:  Takumi Nakano; Shunichi Takeda; J B Brown
Journal:  RSC Med Chem       Date:  2020-07-20

2.  CATMoS: Collaborative Acute Toxicity Modeling Suite.

Authors:  Kamel Mansouri; Agnes L Karmaus; Jeremy Fitzpatrick; Grace Patlewicz; Prachi Pradeep; Domenico Alberga; Nathalie Alepee; Timothy E H Allen; Dave Allen; Vinicius M Alves; Carolina H Andrade; Tyler R Auernhammer; Davide Ballabio; Shannon Bell; Emilio Benfenati; Sudin Bhattacharya; Joyce V Bastos; Stephen Boyd; J B Brown; Stephen J Capuzzi; Yaroslav Chushak; Heather Ciallella; Alex M Clark; Viviana Consonni; Pankaj R Daga; Sean Ekins; Sherif Farag; Maxim Fedorov; Denis Fourches; Domenico Gadaleta; Feng Gao; Jeffery M Gearhart; Garett Goh; Jonathan M Goodman; Francesca Grisoni; Christopher M Grulke; Thomas Hartung; Matthew Hirn; Pavel Karpov; Alexandru Korotcov; Giovanna J Lavado; Michael Lawless; Xinhao Li; Thomas Luechtefeld; Filippo Lunghini; Giuseppe F Mangiatordi; Gilles Marcou; Dan Marsh; Todd Martin; Andrea Mauri; Eugene N Muratov; Glenn J Myatt; Dac-Trung Nguyen; Orazio Nicolotti; Reine Note; Paritosh Pande; Amanda K Parks; Tyler Peryea; Ahsan H Polash; Robert Rallo; Alessandra Roncaglioni; Craig Rowlands; Patricia Ruiz; Daniel P Russo; Ahmed Sayed; Risa Sayre; Timothy Sheils; Charles Siegel; Arthur C Silva; Anton Simeonov; Sergey Sosnin; Noel Southall; Judy Strickland; Yun Tang; Brian Teppen; Igor V Tetko; Dennis Thomas; Valery Tkachenko; Roberto Todeschini; Cosimo Toma; Ignacio Tripodi; Daniela Trisciuzzi; Alexander Tropsha; Alexandre Varnek; Kristijan Vukovic; Zhongyu Wang; Liguo Wang; Katrina M Waters; Andrew J Wedlake; Sanjeeva J Wijeyesakere; Dan Wilson; Zijun Xiao; Hongbin Yang; Gergely Zahoranszky-Kohalmi; Alexey V Zakharov; Fagen F Zhang; Zhen Zhang; Tongan Zhao; Hao Zhu; Kimberley M Zorn; Warren Casey; Nicole C Kleinstreuer
Journal:  Environ Health Perspect       Date:  2021-04-30       Impact factor: 9.031

3.  Predicting kinase inhibitors using bioactivity matrix derived informer sets.

Authors:  Huikun Zhang; Spencer S Ericksen; Ching-Pei Lee; Gene E Ananiev; Nathan Wlodarchak; Peng Yu; Julie C Mitchell; Anthony Gitter; Stephen J Wright; F Michael Hoffmann; Scott A Wildman; Michael A Newton
Journal:  PLoS Comput Biol       Date:  2019-08-05       Impact factor: 4.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.